Internationally Renowned Neurosurgeon Praises the “No-Swell” Properties of LifeGel for Spine Surgery

Meet Kenneth Renkens, M.D., our esteemed Chief Medical Officer, internationally renowned neurosurgeon, and co-founder of the Indiana Spine Group. With 30 years of experience in the implantable surgical innovation space and involvement in 5 investigational hemostasis spine studies, Dr. Renkens has joined the Medcura team to lead clinical innovation of surgical hemostatic agents.“LifeGel is a particularly meaningful advancement in spine surgery where swelling of current flowable hemostatic agents in confined spaces has been known to cause neurological deficits, including paralysis,” says Dr. Renkens.With invaluable insights from Dr. Renkens, our team is thrilled for the future pioneering that our advanced technology has the potential to bring to spinal procedures.Medcura was recently awarded FDA’s Breakthrough Device Designation for the “no- swell” properties of its LifeGel hemostatic gel. Once approved, LifeGel will be the only absorbable hemostatic agent indicated for use in confined areas and will have the following labeling: “Due to its no-swell properties, LifeGel can be used in surgical procedures where swelling cannot be tolerated.”